20 employees
Xalud Therapeutics is a biotech company that develops therapies for the treatment of neuro-inflammatory diseases.
2009
$30M
from 1 investors over 1 rounds
Xalud Therapeutics, Inc. raised $30M on August 24, 2021
Investors: PBM Capital Group